Mutabilis' Series B Round

Mutabilis raised a round of funding on July 11, 2004.

Mutabilis is a biopharmaceutical company specialised in antibacterial drugs. It was founded in 2001 by Xavier Nassif, professor of microbiology at the Necker medical school in Paris and head of Inserm…

Articles about Mutabilis' Series B Round: